Mia's Feed
Medical News & Research

Prenatal Cannabis Exposure May Disrupt Reproductive Development Across Generations

Prenatal Cannabis Exposure May Disrupt Reproductive Development Across Generations

Share this article

A groundbreaking study links cannabis use during pregnancy to delayed reproductive development in female offspring, with effects spanning multiple generations. Learn more about the implications for maternal and long-term reproductive health.

2 min read

A recent study conducted by Washington State University reveals that cannabis use during pregnancy and nursing can have lasting effects on the reproductive health of female offspring, extending even to subsequent generations. The research, published in Toxicological Sciences, involved exposing female mice to vaporized cannabis extract from the start of pregnancy until their offspring were weaned. The findings showed that females directly exposed to cannabis produced smaller litters, experienced delayed puberty, and had irregular reproductive cycles. Notably, these effects were most pronounced in the first generation and became less severe in the second, with no significant symptoms observed by the third generation.

While the study indicated that cannabis exposure did not influence pregnancy duration, litter size, or survival rates, the early developmental delays observed in first-generation females suggest a direct impact on reproductive maturation. This highlights concerns about the safety of cannabis use during pregnancy, despite its legal status in 24 U.S. states and Washington, D.C. Cannabis remains the most widely used recreational drug in the country, with over 48 million users annually. However, health authorities like the American College of Obstetricians and Gynecologists strongly advise against its use during pregnancy and breastfeeding due to risks such as low birth weight and impaired brain development.

The researchers replicated human consumption by exposing female mice to vaporized cannabis twice daily throughout pregnancy and lactation, then analyzing outcomes across three generations. Interestingly, the study showed that maternal reproductive parameters remained unaffected, suggesting that the reproductive delays are likely due to developmental disruptions caused by cannabis exposure rather than pregnancy complications.

In addition to its direct effects, the study emphasizes the importance of considering mixed substance use during pregnancy, as many women also consume alcohol, tobacco, or other drugs. Her team is now exploring whether male offspring are similarly impacted, with preliminary results indicating more severe reproductive effects in males.

The findings underscore the need for awareness around the potential long-term reproductive consequences of cannabis use during pregnancy and the importance of ongoing research in this area.

For more details, see the original publication: Mingxin Shi et al, Transgenerational effects of perinatal cannabis exposure on female reproductive parameters in mice, Toxicological Sciences (2025). DOI: 10.1093/toxsci/kfaf043.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Understanding Thyroid Cancer: Risks, Symptoms, and Treatment Options

Learn about the risks, symptoms, and treatment options for thyroid cancer. Early detection and personalized care are key to effective management of this common but often silent disease.

Identifying Who Is Most at Risk of Missing Follow-Up Care for Diabetic Eye Disease

A new study identifies key sociodemographic factors that increase the risk of missed follow-up care in diabetic eye disease, emphasizing the need for targeted strategies to prevent vision loss.

Research Links Placental Inflammation to Childhood Allergic Diseases Like Asthma

New research uncovers how placental inflammation during pregnancy influences the development of allergic diseases like pediatric asthma, offering insights into early prediction and prevention.

Blood Sugar-Lowering GLP-1 Therapy Shows Promise in Reducing Migraine Frequency

A groundbreaking study shows that the blood sugar medication liraglutide may reduce migraine frequency by lowering intracranial pressure, offering hope for new treatment strategies.